Literatur
Zhao E, Zhang Y, Zeng X, Liu B (2015) Association between maternal diabetes mellitus and the risk of congenital malformations: a meta-analysis of cohort studies. Drug discoveries & therapeutics
Martínez-Frías ML, Rodríguez-Pinilla E, Bermejo E et al (2002) Epidemiological evidence that maternal diabetes does not appear to increase the risk for Down syndrome. Am J Med Genet 112(4):335–337
Alexander EK, Pearce EN, Brent GA et al (2017) 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27(3):315–389
Temple RC, Aldridge VA, Sampson MJ et al (2001) Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet Med 18(7):573–577
Bain SC, Klufas MA, Ho A et al (2019) Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review. Diabetes Obes Metab 21(3):454–466
Farrar D, Tuffnell DJ, West J et al (2016) Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005542.pub3
Ranasinghe PD, Maruthur NM, Nicholson WK et al (2015) Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: A systematic review and meta-analysis. J Womens Health 24(3):237–249
Bell R, Glinianaia SV, Tennant PWG et al (2012) Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: A population-based cohort study. Diabetologia 55:936
Mackensen F, Paulus WE, Max R et al (2014) Ocular changes during pregnancy. Dtsch Arztebl Int 111(33–34):567–575 (quiz 576)
Hauffe F, Schaefer-Graf UM, Fauzan R et al (2019) Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection. Diabet Med 36(2):158–166
Feig DS, Corcoy R, Donovan LE, Murphy KE, Barrett JFR, Sanchez JJ, Wysocki T, Ruedy K, Kollman C, Tomlinson G, Murphy HR (2018) Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care 41(12):2471–2479. https://doi.org/10.2337/dc18-1437
Alessi J, Wiegand DM, Hirakata VN, Oppermann MLR, Reichelt AJ (2018) Temporal changes in characteristics and outcomes among pregnant women with pre-gestational diabetes. Int J Gynaecol Obstet 143(1):59–65. https://doi.org/10.1002/ijgo.12590
Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, Leese GP, Philip S, Lindsay RS; SDRN Epidemiology Group (2018) Diabetes and pregnancy: national trends over a 15 year period. Diabetologia 61(5):1081–1088. https://doi.org/10.1007/s00125-017-4529-3
Padmanabhan S, Zen M, Lee V, Cheung NW (2016) Pre-existing diabetes in pregnancy. Minerva Endocrinol 41(1):122–37
Durackova L, Kristufkova A, Korbel M (2017) Pregnancy and neonatal outcomes in women with type 1 diabetes mellitus. Bratisl Lek Listy 118(1):56–60. https://doi.org/10.4149/BLL_2017_011
Sperling JD, Maggio L, Has P, Daley J, Khander A, Coustan DR (2018) Prenatal Care Adherence and Neonatal Intensive Care Unit Admission or Stillbirth among Women with Gestational and Preexisting Diabetes Mellitus. Am J Perinatol 35(2):103–109. https://doi.org/10.1055/s-0037-1603343
Wotherspoon AC, Young IS, Patterson CC, McCance DR, Holmes VA; Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group (2017) Effect of pregnancy planning on maternal and neonatal outcomes in women with Type 1 diabetes. Diabet Med 34(9):1303–1308. https://doi.org/10.1111/dme.13398
Chico A, Herranz L, Corcoy R, Ramírez O, Goya MM, Bellart J, González-Romero S, Codina M, Sánchez P, Cortázar A, Acosta D, Picón MJ, Rubio JA, Megía A, Sancho MA, Balsells M, Solá E, González NL, López-López J; GEDE (Group of Diabetes and Pregnancy of the Spanish Diabetes Association) (2016) Glycemic control and maternal and fetal outcomes in pregnant women with type 1 diabetes according to the type of basal insulin. Eur J Obstet Gynecol Reprod Biol 206:84–91. https://doi.org/10.1016/j.ejogrb.2016.07.490
Abell SK, Nankervis A, Khan KS, Teede HJ (2016) Type 1 and Type 2 Diabetes Preconception and in Pregnancy: Health Impacts, Influence of Obesity and Lifestyle, and Principles of Management. Semin Reprod Med 34(2):110–120. https://doi.org/10.1055/s-0035-1571196
Melamed N, Ray JG, Geary M et al (2016) Induction of labor before 40 weeks is associated with lower rate of cesarean delivery in women with gestational diabetes mellitus. Am J Obstet Gynecol 214(3):364.e1–364.e8
AWMF [Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften] S2k-LL [Leitlinie] 024/006. 01.07.2017
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Groten gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.
The supplement containing this article is not sponsored by industry.
Additional information
Redaktion
K. Diedrich, Hamburg
M. Friedrich, Krefeld
U. Gembruch, Bonn
W. Jonat, Kiel
A. Rody, Lübeck
Rights and permissions
About this article
Cite this article
Groten, T. 30-jährige schwangere Patientin mit Diabetes mellitus Typ 1. Gynäkologe 53 (Suppl 1), 58–65 (2020). https://doi.org/10.1007/s00129-020-04670-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-020-04670-8